Traditional drug development processes are time-consuming and costly. 3D bioprinting can streamline this process by providing accurate and reproducible models for drug testing. These models can be used to screen potential drug compounds more efficiently, reducing the time and cost associated with bringing new drugs to market. Furthermore, 3D bioprinted tissues can be used to study the toxicity and efficacy of drugs in a more human-relevant context than animal models.
